Animal models are important in investigating the origin and the mechanisms underlying a human disease and designing new therapies, and have been widely used in various areas of medical research. Animal models have not been, however, very popular in psychiatric research. Reproducing psychiatric disorders in animals has often been considered difficult, if not impossible. Modeling schizophrenia is an example of a particularly difficult task, because it is a uniquely human disease, and its most prominent symptoms―hallucinations, delusions, and thought disorder―cannot be reproduced in an animal.

Recent new evidence about the neurobiology of this disease has opened new possibilities of animal research. In particular, abnormalities in the neural circuitry involving the hippocampus, prefrontal cortex, and the dorsomedial thalamus have been reported recently, in addition to previously recognized abnormal function of the dopaminergic system. Cytoarchitectural and molecular studies of the brain, as well as neuropsychological studies showing that schizophrenia symptoms emerge in young adulthood but subtle motor and behavioral abnormalities are present early in life, suggest a neurodevelopmental origin of the disease.

To address a neurodevelopmental origin of schizophrenia, numerous studies modeling schizophrenia in animals have focused on neonatal damage of restricted brain regions in rats^[@ref1]-[@ref11]^ and in monkeys.^[@ref12]-[@ref15]^ The main objective of many of these studies is to disrupt development of the hippocampus, a brain area consistently implicated in human schizophrenia,^[@ref16]-[@ref25]^ and thus disrupt development of the wide-spread cortical and subcortical circuitry in which the hippocampus participates. The lesions were intended to involve regions of the hippocampus that directly project to the prefrontal cortex, ie, ventral hippocampus (VH) and ventral subiculum,^[@ref26],[@ref27]^ and that correspond to the anterior hippocampus in humans, a region that shows anatomical abnormalities in schizophrenia.^[@ref21]^ Valid models would be expected to mimic a wide array of behavioral aspects of the human disorder *(Table I).*

###### Clinical aspects of schizophrenia and relevant behavioral changes in an animal model. DA, dopamine; NMDA, *N*-methyl-D-aspartate; PPI, prepulse inhibition.

  **Schizophrenia**                                   **Animal model**
  --------------------------------------------------- ----------------------------------------------------------------------
  Psychotic symptoms                                  Behaviors related to increased DA transmission
  Stereotypic behaviors                               Dopamimetic-induced stereotypy
  Worsening of symptoms by NMDA antagonists           NMDA antagonists--induced hyper locomotion
  Vulnerability to stress                             Stress-induced hyperlocomotion
  Improvement of psychotic symptoms by neuroleptics   Reduction of hyperlocomotion by neroleptics
  Information-processing deficits                     Sensorimotor gating (PPI) deficits
  Attention deficits                                  Deficits in latent inhibition
  Cognitive deficits                                  Impaired performance in delayed alternation and spatial memory tasks
  Social withdrawal                                   Reduced contacts with unfamiliar partners
  Anhedonia                                           Diminished sensitivity to rewarding stimuli

Neonatal excitotoxic VH lesions alter development of prefrontal cortex
======================================================================

In a series of studies, we have shown that neonatal excitotoxic lesions of the rat VH lead in adolescence to the emergence of abnormalities in a number of dopamine-related behaviors.^[@ref28]^ When tested as juveniles (postnatal day 35 \[PD35\]), rats with the neonatal VH lesions are less social than controls,^[@ref29]^ but otherwise behave normally in motor tests involving exposure to stress and dopamine agonists. In adolescence and adulthood (PD56 and older), lesioned animals display marked changed behaviors thought to be primarily linked to increased mesolimbic/ nigrostriatal dopamine transmission (motor hyperresponsiveness to stress and stimulants, enhanced stereotypics). They also show enhanced sensitivity to glutamate antagonists (MK-801 and phencyclidine \[PCP\]), deficits in prepulse inhibition (PPI) and latent inhibition, impaired social behaviors, and working memory problems,^[@ref9],[@ref10],[@ref30]-[@ref38]^ phenomena showing many parallels with schizophrenia *([Figure 1](#DialoguesClinNeurosci-4-361-g001){ref-type="fig"}).* ^[@ref37]^

![Effects of the glutamate antagonist MK-801 (0.05 \[MK0.05\], 0.1 \[MK0.1 \], and 0.2 \[MK0.2\] mg/kg) on locomotion (A) and stereotypy (B) in sham and ventral hippocampus (VH)--lesioned rats. Rats were lesioned as neonates at postnatal day 7 and tested at three ages: 35, 65, and 150 days. At all ages tested, only the highest dose of MK-801 (0.2 mg/kg) significantly increased locomotion (total distance traveled in cm) in the sham-operated rats as compared with the saline injection. In the lesioned rats, only 0.2 mg/kg MK-801 significantly increased locomotion at postnatal days 35 and 65, but all three doses were effective at 150 days of age as compared with saline. Neonatally lesioned animals showed significantly more locomotion and stereotypies than controls at days 65 and 150, but not at day 35. \*Signif icantly higher than controls that received the same dose of MK-801 (P\<0.05); sham n=5 per dose group; lesion n=6 per dose group.\
Reproduced from reference 37: Al-A.min HA, Weickert CS, Lilirank SM, Weinberger DR, Lipska BK. Deiayed onset of enhanced MK-801-induced motor hyperactivity after neonata! iesions of the rat ventral hippocampus. *Biol Psychiatry.* 2001:49:528-539. Copyright © 2001, Elsevier Science.](DialoguesClinNeurosci-4-361-g001){#DialoguesClinNeurosci-4-361-g001}

Emergence of the behavioral changes in adolescence appears not to be related to the surge of gonadal hormones during puberty because a similar temporal pattern of abnormalities is observed in animals depleted of gonadal hormones prior to puberty.^[@ref32]^ Notably, removal of prefrontal neurons in adult, animals with the earlier hippocampal lesion restores some of the behaviors (ie, those modulated by, but not critically dependent on, the prefrontal cortex, such as hyperlocomotion after amphetamine), suggesting that aberrant development of the prefrontal cortex in the context of early damage to the hippocampus may be a. critical factor in the expression of the syndrome.^[@ref39]^ In this context, it is important to emphasize that anatomical findings from postmortem studies and neuropsychological and neuroimaging studies of brain function in patients with schizophrenia, have implicated prefrontal cortical maldevelopment and a developmental disconnection of the tcmporolimbic and prefrontal cortices.^[@ref40]^ Although the exact mechanisms of a seemingly similar disconnection and malfunction of the prefrontal cortex in the VH-lesioned rats need to be elucidated, preliminary findings from molecular and electrophysiological studies (such as reduced cortical levels of *N*-acetyl-aspartate \[NAA\], attenuated stress-induced cortical dopamine release, attenuated cortical expression of a membrane glutamate transporter EAAC1 and of a. synthetic enzyme for γ-aminobutyric acid \[GABA\], glutamate decarboxylase-67 \[GAD67\], reduced brain-derived neurotrophic factor \[BDNF\] expression, altered cortical expression of transcription factors, c-fos and AfosB, as well as altered firing pattern of cortical pyramidal neurons in response to ventral tegmental area \[VTA\] stimulation) suggest that aberrant cortical dopamine/glutamate/GABA interactions may underlie cortical dysfunction in neonatally VH-lesionedrats.^[@ref34],[@ref41]-[@ref44]^

We have recently reported that cxcitotoxic prefrontal cortical lesions in adult, animals cause downstream striatal NAA losses and reduced GAD-67 mRNA expression, and suggested that both changes might reflect transsynaptic pathology.^[@ref45]^ It is possible that similar transsynaptic events occur in response to the neonatal VH lesion, but. further work is required to determine if, and by what mechanisms, molecular changes in prefrontal neurons are linked.

Neonatal VH lesions mimic aspects of psychostimulant sensitization
==================================================================

It is interesting to note that many of these changes have been reported in stress- and psychostimulant-sensitization models,^[@ref46]-[@ref48]^ as well as in patients with schizophrenia.^[@ref49],[@ref50]^

Subcortical function in the neonatally lesioned rats is also altered in a fashion consistent with at least some reports on behavioral sensitization,^[@ref51]-[@ref54]^ ie, striatal dopamine release is attenuated in response to stress and amphetamine, midbrain expression of the membrane dopamine transporter (DAT) mRNA is reduced, striatal expression of dynorphin (an opioid peptide colocalized with dopamine D~1~ receptors) and ΔfosB (a. transcription factor sensitive to persistent stimulation) is enhanced.^[@ref42],[@ref55]^ It should be noted, however, that enhanced rather than attenuated striatal dopamine release has been observed in other paradigms of sensitization to psychostimulants,^[@ref56]^ as well as in a subgroup of patients with schizophrenia as evidenced by recent, single-photon emission computed tomography (S.PECT) studies.^[@ref57]-^[@ref59]^^ Similarly discrepant are the findings of synaptic morphology: increased synaptic densities, number of branches, and dendritic length are reported in prefrontal cortex in sensitization models,^[@ref60]^ whereas these dendritic parameters are decreased in schizophrenia^[@ref61]^ and in the neonatal hippocampal lesion model.^[@ref62]^ Nevertheless, an array of behavioral and molecular changes associated with this model suggest that early developmental insult of the VH may facilitate sensitization of the dopamine system, and thereby account for the adult onset of a maladaptive condition characterized by a variety of dopamine-related abnormalities. Similar pathophysiological mechanisms have been hypothesized to underlie schizophrenia.^[@ref63]-[@ref65]^

Unlike psychostimulant-sensitization models, however, the neonatal lesion model does not target, the dopamine system directly and similar sensitization-likc phenomena are not seen following an analogous hippocampal lesion in adult animals. It may be of considerable heuristic interest to determine how the developmental lesion initiates the subsequent behavioral and molecular phenomena associated with sensitization.

In terms of the predictive validity of the neonatal VH lesion model, antipsychotic drugs normalize some lesioninduced behaviors.^[@ref29],[@ref31]^ Drugs targeting the glutamate system may also prove beneficial; LY293558, an aminoiso propyl propionic acid (AMPA) antagonist, is highly efficient in blocking hyperlocomotion in the neonatally lesioned rats at doses that do not affect, locomotor activity in controls,^[@ref36]^ as is the glycine transporter inhibitor.^[@ref66]^ Thus, this model may have predictive validity and heuristic potential to identify drugs with new mechanisms of action. The model also appears to mimic a spectrum of neurobiological and behavioral features of schizophrenia, including functional pathology in presumably critical brain regions interconnected with the hippocampal formation and targeted by antipsychotic drugs: the striatum/nucleus accumbens and the prefrontal cortex. It is noteworthy that in the nonhuman primate, early postnatal damage of the hippocampal region also alters development of the dorsal prefrontal cortex and the mechanisms whereby the dorsal prefrontal cortex regulates subcortical dopamine function, phenomena similar to those described in patients with schizophrenia.^[@ref13],[@ref14],[@ref67]^ Thus, neonatal damage to the hippocampus of the rat appears to reproduce a broad spectrum of schizophrenia-related phenomena *(Table I),* and establishes the neurobiological plausibility of early damage having a delayed impact on neural functions implicated in schizophrenia.

Transient VH inactivation model
===============================

Although developmental lesion models represent a. rather crude technique to study the role of particular brain regions, transmitter systems, or the connections between them, they have confirmed the plausibility of neurodevelopmental damage having selected deleterious effects after a prolonged period of relative normalcy. In this respect, they appear to have face validity not just, in terms of behavioral, cellular, and pharmacological phenomena, but also in terms of the temporal course of the clinical disorder. As models of developmental pathology, they certainly lack construct validity, as the schizophrenic brain does not manifest a "lesion" analogous to any of these models; but they may have heuristic value in discovering molecular consequences of early brain damage and new treatment strategies.

In the next series of studies, we hypothesized that transient inactivation of the VH during a critical period of development, that produces subtle, if any, anatomical changes in the hippocampus, may be sufficient, to disrupt, normal maturation of the prefrontal cortex (and perhaps, other interconnected late maturing regions). We explored whether this developmental disruption would, in turn, trigger behavioral changes similar to those observed in animals with the permanent excitotoxic lesion. We used tetrodotoxin (TTX), a potent and specific blocker of the voltage-gated sodium channels, whose action is fully reversible, to inactivate VH on PD7, an important time for refinement of intracortical connections, and then assessed behavioral changes that this infusion might have evoked later in life, in juvenile (PD35) and young adult (PD56) rats.^[@ref68]^ The overall characteristics of behavioral changes and their temporal pattern were reminiscent of the disturbances associated with the permanent cxcitotoxic lesion of the VH produced at. the same neonatal age *([Figure 2](#DialoguesClinNeurosci-4-361-g002){ref-type="fig"}).* ^[@ref40],[@ref68]^ Neonatally TTX-infused rats displayed adulthood motor hyperactivity upon pharmacological stimulation (amphetamine and MK-801) and after stress of novelty and a saline injection as compared with sham controls. The magnitude of TTX-induced behavioral disruptions was smaller, however, than those observed after the excitotoxic lesion (eg, ibotcnic acid lesions of the VH increased spontaneous and amphetamine-induced locomotor activity by approximately 50% as compared with controls,^[@ref30],[@ref33],[@ref34]^ whereas TTX produced increases by about 15% to 20%). Moreover, in contrast, to the permanent lesion, TTX infusions did not significantly affect, social behaviors, although a. trend for reduced social interactions mimicked again a. pattern seen after the permanent lesions. Analogous TTX infusions in adult animals did not alter these behaviors later in life. It is unclear how such a transient and restricted blockade of ventral hippocampal activity in neonatal life can permanently alter brain function. One possibility is that neonatal blockade impacts on the development of neurons in the hippocampal formation and interconnected systems that also undergo important maturational changes at. this time. These data, suggest, that transient loss of VH function during a critical time in maturation of intracortical connections permanently changes development of neural circuits mediating certain dopamine- and *N*-methyl-D-aspartatc (NMDA)--related behaviors. These results represent, a potential new model of aspects of schizophrenia without, a. gross anatomical lesion.

![Locomotor activity (total distance traveled) in rats with neonatal tetrodotoxin (TTX) infusions. Rats were tested in photocell monitors at postnatal day 35 (PD35) and 56 (PD56) after exposure to novelty (Nov), after saline injection (Sal), and amphetamine administration (AMPH, 1.5 mg/kg, IP). TTX-infused rats were significantly more active than sham rats (\* P\<0.05; n=13 to 16 per group).\
Reproduced from reference 68: Lipska BK, Halim ND, Segal PN, Weinberger DR. Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. *J Neumsci.* 2002;22:2835-2842. Copyright © 2002, Society for Neuroscience.](DialoguesClinNeurosci-4-361-g002){#DialoguesClinNeurosci-4-361-g002}
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